Literature DB >> 9059398

SIPAP--a new MR classification for pituitary adenomas. Suprasellar, infrasellar, parasellar, anterior and posterior.

A L Edal1, K Skjödt, H J Nepper-Rasmussen.   

Abstract

PURPOSE: To present a new MR classification for pituitary adenomas, a grading system named SIPAP.
MATERIAL AND METHODS: SIPAP is an acronym for the 5 juxtasellar directions of tumour extension to or penetration into adjacent structures of the sella region, using a 6-figure number for each adenoma. This retrospective study was based on 87 mid-field MR examination of 56 patients with biochemically or surgically confirmed pituitary adenomas. Sagittal T1-weighted SE and coronal T1-weighted 3D FFE sequences before and after i.v. contrast administration were performed.
RESULTS: The SIPAP classification was well adapted to the material. All tumours except one postoperative remnant could be classified in the grading system. The classification was useful before and after treatment, for follow-up over a longer period, and for comparing adenomas with different hormonal activity with reference to patient age and sex.
CONCLUSION: The SIPAP classification together with tumour size is an optimal method for the registration of pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059398     DOI: 10.1080/02841859709171238

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  13 in total

1.  Transnasal Transsphenoidal Approach for Pituitary Tumors: An ENT Perspective.

Authors:  Vaibhav A Chandankhede; S K Singh; Ravi Roy; Sunil Goyal; M S Sridhar; M S Gill
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-02-11

2.  Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly.

Authors:  Ansgar Heck; Kyrre E Emblem; Olivera Casar-Borota; Jens Bollerslev; Geir Ringstad
Journal:  Endocrine       Date:  2015-10-16       Impact factor: 3.633

3.  Recovery of Cranial Nerve Deficits in Patients Presenting with Pituitary Apoplexy: A Case Series.

Authors:  Mohammed Alahmari; Fahad Alkherayf; Andrea Lasso; Fatmahalzahra Banaz; Sepideh Mohajeri; Pourya Masoudian; Andre Lamothe; Charles Agbi; Lisa Caulley; Mohammad Alshardan; Shaun Kilty
Journal:  J Neurol Surg B Skull Base       Date:  2021-01-21

4.  Clinical analysis of infarction in pituitary adenoma.

Authors:  Deyong Xiao; Shousen Wang; Yinxing Huang; Lin Zhao; Liangfeng Wei; Chenyu Ding
Journal:  Int J Clin Exp Med       Date:  2015-05-15

5.  Expression of pituitary tumor transforming gene (PTTG) in human pituitary macroadenomas.

Authors:  Wang Jia; Runchun Lu; Guijun Jia; Ming Ni; Zhiqing Xu
Journal:  Tumour Biol       Date:  2013-02-13

6.  Pituitary magnetic resonance imaging predictive role in the therapeutic response of growth hormone-secreting pituitary adenomas.

Authors:  Fabio Tortora; Alberto Negro; Ludovica F S Grasso; Annamaria Colao; Rosario Pivonello; Alessandra Splendiani; Luca Brunese; Ferdinando Caranci
Journal:  Gland Surg       Date:  2019-09

7.  Comparison of post-surgical MRI presentation of the pituitary gland and its hormonal function.

Authors:  Joanna Bladowska; Violetta Sokolska; Tomasz Sozański; Grażyna Bednarek-Tupikowska; Marek Sąsiadek
Journal:  Pol J Radiol       Date:  2010-01

8.  Three-dimensional reconstruction and morphological characterization of pituitary macroadenomas.

Authors:  Shou-Sen Wang; Lin Wei; Jun-Jie Jing; Shang-Ming Zhang
Journal:  Arch Med Sci       Date:  2016-05-18       Impact factor: 3.318

9.  Prognostic Value of Invasion, Markers of Proliferation, and Classification of Giant Pituitary Tumors, in a Georeferred Cohort in Brazil of 50 Patients, with a Long-Term Postoperative Follow-Up.

Authors:  Juliano Coelho de Oliveira Zakir; Luiz Augusto Casulari; José Wilson Corrêa Rosa; João Willy Corrêa Rosa; Paulo Andrade de Mello; Albino Verçosa de Magalhães; Luciana Ansaneli Naves
Journal:  Int J Endocrinol       Date:  2016-08-18       Impact factor: 3.257

10.  Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases.

Authors:  Maria de Fátima de Magalhães Gonzaga; Lucas Faria de Castro; Luciana Ansaneli Naves; José Luiz Mendonça; Benicio Oton de Lima; Iruena Kessler; Luiz Augusto Casulari
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-13       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.